FDA Approved: GABAPENTIN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a generic gabapentin product from Rising Pharma Holdings, Inc. under an Original Application (ANDA217995).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)